Determination of Dosing Guidelines for Stavudine (2′,3′-Didehydro-3′-Deoxythymidine) in Children with Human Immunodeficiency Virus Infection
Sanjeev Kaul(AstraZeneca (United States)), Lisa M. Dunkle(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joseph A. Church(University of Southern California), Mark W. Kline(Tulane University)
Cited by 16
Related Papers
The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi
|Journal of the International AIDS Society|2012|145
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
|Journal for ImmunoTherapy of Cancer|2022|140
Primary iris cysts: a review of the literature and report of 62 cases.
|British Journal of Ophthalmology|1984|135
Lipodystrophy syndrome in human immunodeficiency virus-infected children
|The Pediatric Infectious Disease Journal|2002|124
Excess Intrauterine Fetal Demise Associated with Maternal Human Immunodeficiency Virus Infection
|The Journal of Infectious Diseases|1995|110